Exeter Cardiology Group Ltd 16244899 false 2025-02-11 2026-02-28 2026-02-28 The principal activity of the company is Specialists medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 16244899 2025-02-11 2026-02-28 16244899 2026-02-28 16244899 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 16244899 bus:Micro-entities 2025-02-11 2026-02-28 16244899 bus:AuditExemptWithAccountantsReport 2025-02-11 2026-02-28 16244899 bus:FilletedAccounts 2025-02-11 2026-02-28 16244899 bus:SmallCompaniesRegimeForAccounts 2025-02-11 2026-02-28 16244899 bus:RegisteredOffice 2025-02-11 2026-02-28 16244899 bus:Director1 2025-02-11 2026-02-28 16244899 bus:Director2 2025-02-11 2026-02-28 16244899 bus:PrivateLimitedCompanyLtd 2025-02-11 2026-02-28 16244899 countries:EnglandWales 2025-02-11 2026-02-28 iso4217:GBP xbrli:pure

Registration number: 16244899

Exeter Cardiology Group Ltd

Unaudited Filleted Financial Statements

for the period from 11 February 2025 to 28 February 2026
 

 

Exeter Cardiology Group Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Exeter Cardiology Group Ltd

Company Information

Directors

Dr A K Kotecha

Mrs V B Banthia

Registered office

Redwoods
2 Clyst Works
Clyst Road, Topsham
Exeter
Devon
EX3 0DB

 

Exeter Cardiology Group Ltd

(Registration number: 16244899)
Balance Sheet as at 28 February 2026

2026
£

Fixed assets

1,466

Current assets

5,861

Creditors: Amounts falling due within one year

(707)

Net current assets

5,154

Total assets less current liabilities

6,620

Accruals and deferred income

(2,437)

 

4,183

Capital and reserves

4,183

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Redwoods
2 Clyst Works
Clyst Road, Topsham
Exeter
Devon
EX3 0DB

These financial statements were authorised for issue by the Board on 22 October 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

For the financial period ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

•

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 October 2026 and signed on its behalf by:
 

 

Exeter Cardiology Group Ltd

(Registration number: 16244899)
Balance Sheet as at 28 February 2026

.........................................
Dr A K Kotecha
Director